Followers | 182 |
Posts | 12762 |
Boards Moderated | 0 |
Alias Born | 12/08/2009 |
Sunday, March 29, 2020 1:36:54 AM
Punchline:
The Board of Directors decided that it is in the best interests of the Company and its stockholders to extend the time to determine the ratio of the Reverse Split for an additional one hundred eighty (180) days in order to: (i) evaluate the success of its capital raising efforts; and (ii) the growth of its operations during the extension.
Quote:
REVERSE SPLIT
On September 11, 2019, the Company’s Board of Directors unanimously approved the of the Reverse Split of the issued and outstanding shares of Common Stock, including shares of Common Stock reserved for issuance, in a ratio and at a time and date to be determined by the Company’s Board of Directors, not to exceed a one-for-one thousand (1:000) basis within one hundred eighty (180) days from the date of filing of this amended Definitive Information Statement on Form 14C with the SEC. The Board of Directors decided that it is in the best interests of the Company and its stockholders to extend the time to determine the ratio of the Reverse Split for an additional one hundred eighty (180) days in order to: (i) evaluate the success of its capital raising efforts; and (ii) the growth of its operations during the extension.
Recent GXXM News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:15:53 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 11/13/2023 09:11:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:38:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:22:30 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/21/2023 08:00:34 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 02:09:47 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM